Clinical characteristics in Taiwanese women with polycystic ovary syndrome
Ming-I Hsu
Clin Exp Reprod Med. 2015;42(3):86-93.   Published online 2015 Sep 30     DOI: https://doi.org/10.5653/cerm.2015.42.3.86
Citations to this article as recorded by Crossref logo
The prescription patterns of traditional Chinese medicine for women with polycystic ovary syndrome in Taiwan
Mei-Jiun Lin, Hsiao-Wei Chen, Pi-Hua Liu, Wei-Jen Cheng, Shun-Li Kuo, Ming-Chen Kao
Medicine.2019; 98(24): e15890.     CrossRef
Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
Hsin-Yi Yang, Herng-Sheng Lee, Wan-Ting Huang, Ming-Jer Chen, Solomon Chih-Cheng Chen, Yueh-Han Hsu
Journal of Bone and Mineral Metabolism.2018; 36(6): 741.     CrossRef
Effect of IGF-I and TNF-α on intensification of steroid pathways in women with PCOS phenotypes are not identical. Enhancement of progesterone pathway in women with PCOS increases the concentration of TNF-α
M. Szczuko, M. Zapałowska-Chwyć, A. Drozd, D. Maciejewska, A. Starczewski, E. Stachowska
Gynecological Endocrinology.2016; 32(9): 714.     CrossRef
Current aspects of polycystic ovary syndrome: A literature review
VICTOR HUGO LOPES DE ANDRADE, ANA MARIA OLIVEIRA FERREIRA DA MATA, RAFAEL SOARES BORGES, DANYLO RAFHAEL COSTA-SILVA, LUANA MOTA MARTINS, PAULO MICHEL PINHEIRO FERREIRA, LÍVIO CÉSAR CUNHA-NUNES, BENEDITO BORGES DA SILVA
Revista da Associação Médica Brasileira.2016; 62(9): 867.     CrossRef